[Development of KRN7000, derived from agelasphin produced by Okinawan sponge]
- PMID: 9503408
- DOI: 10.1254/fpj.110.supplement_63
[Development of KRN7000, derived from agelasphin produced by Okinawan sponge]
Abstract
New glycosphingolipids, named agelasphins, have been isolated as antitumoral compounds from an extract of a marine sponge, Agelas mauritianus. The absolute configurations of agelasphins were elucidated by the total synthesis. Various analogues of agelasphins were also synthesized and the relationship between their structures and biological activities was examined using an MLR assay. From the results, KRN7000, (2S,3S,4R)-1-O-(alpha-D- galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol , was selected as a candidate for clinical application. KRN7000 markedly stimulated lymphocytic proliferation in allogeneic MLR, and showed potent tumor growth inhibitory activities in B16-bearing mice and strongly inhibited tumor metastasis, suggesting that KRN7000 is a potent biological response modifier. These biological effects were exerted by the activation of dendritic cells by KRN7000.
Similar articles
-
Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice.J Med Chem. 1995 Jun 9;38(12):2176-87. doi: 10.1021/jm00012a018. J Med Chem. 1995. PMID: 7783149
-
Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.Oncol Res. 1996;8(10-11):399-407. Oncol Res. 1996. PMID: 9114432
-
Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4 - octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice.Oncol Res. 1996;8(4):155-62. Oncol Res. 1996. PMID: 8869965
-
Structure-activity relationship studies of novel glycosphingolipids that stimulate natural killer T-cells.Biosci Biotechnol Biochem. 2012;76(6):1055-67. doi: 10.1271/bbb.120072. Epub 2012 Jun 7. Biosci Biotechnol Biochem. 2012. PMID: 22790924 Review.
-
[Anti-tumor activity of KRN7000, an alpha-galactosylceramide and its action mechanism].Tanpakushitsu Kakusan Koso. 2000 Apr;45(6 Suppl):1193-8. Tanpakushitsu Kakusan Koso. 2000. PMID: 10771695 Review. Japanese. No abstract available.
Cited by
-
Harnessing NKT cells for vaccination.Oxf Open Immunol. 2021 Jun 19;2(1):iqab013. doi: 10.1093/oxfimm/iqab013. eCollection 2021. Oxf Open Immunol. 2021. PMID: 36845569 Free PMC article. Review.
-
Activation strategies for invariant natural killer T cells.Immunogenetics. 2016 Aug;68(8):649-63. doi: 10.1007/s00251-016-0944-8. Epub 2016 Jul 25. Immunogenetics. 2016. PMID: 27457886 Free PMC article. Review.
-
Oral administration of DNA alginate nanovaccine induced immune-protection against Helicobacter pylori in Balb/C mice.BMC Immunol. 2024 Feb 3;25(1):11. doi: 10.1186/s12865-024-00602-6. BMC Immunol. 2024. PMID: 38310250 Free PMC article.
-
Boosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvants.Front Biol (Beijing). 2012 Oct 1;7(5):436-444. doi: 10.1007/s11515-012-1194-2. Front Biol (Beijing). 2012. PMID: 23264781 Free PMC article.
-
How do natural killer T cells help B cells?Expert Rev Vaccines. 2009 Aug;8(8):1109-21. doi: 10.1586/erv.09.56. Expert Rev Vaccines. 2009. PMID: 19627191 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources